ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tumor Embolization Device Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-31S11385
Home | Market Reports | Health| Health Conditions| Cancer
Global Tumor Embolization Device Market Research Report 2022
BUY CHAPTERS

Global Tumor Embolization Device Market Research Report 2024

Code: QYRE-Auto-31S11385
Report
May 2024
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boston Scientific Corporation
Medtronic Inc
Terumo Corporation
Sirtex Medical Ltd.
Merit Medical
Cook Meidical LLC
BTG Plc
AngioDynamics
Siemens Healthineers

Tumor Embolization Device Market

The global Tumor Embolization Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tumor Embolization Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tumor Embolization Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tumor Embolization Device include Boston Scientific Corporation, Medtronic plc., Terumo Corporation, Sirtex Medical ltd., Merit Medical, Cook Meidical LLC, BTG plc., Angiodynamics and Siemens Healthineers, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tumor Embolization Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Embolization Device.

Report Scope

The Tumor Embolization Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Embolization Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Embolization Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Tumor Embolization Device Market Report

Report Metric Details
Report Name Tumor Embolization Device Market
Segment by Type
  • Cancer Tumors Embolization Device
  • Noncancerous Tumors Embolization Device
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boston Scientific Corporation, Medtronic plc., Terumo Corporation, Sirtex Medical ltd., Merit Medical, Cook Meidical LLC, BTG plc., Angiodynamics, Siemens Healthineers
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tumor Embolization Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tumor Embolization Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tumor Embolization Device Market report?

Ans: The main players in the Tumor Embolization Device Market are Boston Scientific Corporation, Medtronic plc., Terumo Corporation, Sirtex Medical ltd., Merit Medical, Cook Meidical LLC, BTG plc., Angiodynamics, Siemens Healthineers

What are the Application segmentation covered in the Tumor Embolization Device Market report?

Ans: The Applications covered in the Tumor Embolization Device Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Tumor Embolization Device Market report?

Ans: The Types covered in the Tumor Embolization Device Market report are Cancer Tumors Embolization Device, Noncancerous Tumors Embolization Device

1 Tumor Embolization Device Market Overview
1.1 Product Overview and Scope of Tumor Embolization Device
1.2 Tumor Embolization Device Segment by Type
1.2.1 Global Tumor Embolization Device Market Value Comparison by Type (2024-2030)
1.2.2 Cancer Tumors Embolization Device
1.2.3 Noncancerous Tumors Embolization Device
1.3 Tumor Embolization Device Segment by Application
1.3.1 Global Tumor Embolization Device Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Tumor Embolization Device Market Size Estimates and Forecasts
1.4.1 Global Tumor Embolization Device Revenue 2019-2030
1.4.2 Global Tumor Embolization Device Sales 2019-2030
1.4.3 Global Tumor Embolization Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tumor Embolization Device Market Competition by Manufacturers
2.1 Global Tumor Embolization Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tumor Embolization Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tumor Embolization Device Average Price by Manufacturers (2019-2024)
2.4 Global Tumor Embolization Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tumor Embolization Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tumor Embolization Device, Product Type & Application
2.7 Tumor Embolization Device Market Competitive Situation and Trends
2.7.1 Tumor Embolization Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tumor Embolization Device Players Market Share by Revenue
2.7.3 Global Tumor Embolization Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tumor Embolization Device Retrospective Market Scenario by Region
3.1 Global Tumor Embolization Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tumor Embolization Device Global Tumor Embolization Device Sales by Region: 2019-2030
3.2.1 Global Tumor Embolization Device Sales by Region: 2019-2024
3.2.2 Global Tumor Embolization Device Sales by Region: 2025-2030
3.3 Global Tumor Embolization Device Global Tumor Embolization Device Revenue by Region: 2019-2030
3.3.1 Global Tumor Embolization Device Revenue by Region: 2019-2024
3.3.2 Global Tumor Embolization Device Revenue by Region: 2025-2030
3.4 North America Tumor Embolization Device Market Facts & Figures by Country
3.4.1 North America Tumor Embolization Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tumor Embolization Device Sales by Country (2019-2030)
3.4.3 North America Tumor Embolization Device Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tumor Embolization Device Market Facts & Figures by Country
3.5.1 Europe Tumor Embolization Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tumor Embolization Device Sales by Country (2019-2030)
3.5.3 Europe Tumor Embolization Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tumor Embolization Device Market Facts & Figures by Country
3.6.1 Asia Pacific Tumor Embolization Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tumor Embolization Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Tumor Embolization Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Tumor Embolization Device Market Facts & Figures by Country
3.7.1 Latin America Tumor Embolization Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tumor Embolization Device Sales by Country (2019-2030)
3.7.3 Latin America Tumor Embolization Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tumor Embolization Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Tumor Embolization Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tumor Embolization Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tumor Embolization Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tumor Embolization Device Sales by Type (2019-2030)
4.1.1 Global Tumor Embolization Device Sales by Type (2019-2024)
4.1.2 Global Tumor Embolization Device Sales by Type (2025-2030)
4.1.3 Global Tumor Embolization Device Sales Market Share by Type (2019-2030)
4.2 Global Tumor Embolization Device Revenue by Type (2019-2030)
4.2.1 Global Tumor Embolization Device Revenue by Type (2019-2024)
4.2.2 Global Tumor Embolization Device Revenue by Type (2025-2030)
4.2.3 Global Tumor Embolization Device Revenue Market Share by Type (2019-2030)
4.3 Global Tumor Embolization Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tumor Embolization Device Sales by Application (2019-2030)
5.1.1 Global Tumor Embolization Device Sales by Application (2019-2024)
5.1.2 Global Tumor Embolization Device Sales by Application (2025-2030)
5.1.3 Global Tumor Embolization Device Sales Market Share by Application (2019-2030)
5.2 Global Tumor Embolization Device Revenue by Application (2019-2030)
5.2.1 Global Tumor Embolization Device Revenue by Application (2019-2024)
5.2.2 Global Tumor Embolization Device Revenue by Application (2025-2030)
5.2.3 Global Tumor Embolization Device Revenue Market Share by Application (2019-2030)
5.3 Global Tumor Embolization Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boston Scientific Corporation
6.1.1 Boston Scientific Corporation Corporation Information
6.1.2 Boston Scientific Corporation Description and Business Overview
6.1.3 Boston Scientific Corporation Tumor Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boston Scientific Corporation Tumor Embolization Device Product Portfolio
6.1.5 Boston Scientific Corporation Recent Developments/Updates
6.2 Medtronic plc.
6.2.1 Medtronic plc. Corporation Information
6.2.2 Medtronic plc. Description and Business Overview
6.2.3 Medtronic plc. Tumor Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic plc. Tumor Embolization Device Product Portfolio
6.2.5 Medtronic plc. Recent Developments/Updates
6.3 Terumo Corporation
6.3.1 Terumo Corporation Corporation Information
6.3.2 Terumo Corporation Description and Business Overview
6.3.3 Terumo Corporation Tumor Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Terumo Corporation Tumor Embolization Device Product Portfolio
6.3.5 Terumo Corporation Recent Developments/Updates
6.4 Sirtex Medical ltd.
6.4.1 Sirtex Medical ltd. Corporation Information
6.4.2 Sirtex Medical ltd. Description and Business Overview
6.4.3 Sirtex Medical ltd. Tumor Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sirtex Medical ltd. Tumor Embolization Device Product Portfolio
6.4.5 Sirtex Medical ltd. Recent Developments/Updates
6.5 Merit Medical
6.5.1 Merit Medical Corporation Information
6.5.2 Merit Medical Description and Business Overview
6.5.3 Merit Medical Tumor Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merit Medical Tumor Embolization Device Product Portfolio
6.5.5 Merit Medical Recent Developments/Updates
6.6 Cook Meidical LLC
6.6.1 Cook Meidical LLC Corporation Information
6.6.2 Cook Meidical LLC Description and Business Overview
6.6.3 Cook Meidical LLC Tumor Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cook Meidical LLC Tumor Embolization Device Product Portfolio
6.6.5 Cook Meidical LLC Recent Developments/Updates
6.7 BTG plc.
6.6.1 BTG plc. Corporation Information
6.6.2 BTG plc. Description and Business Overview
6.6.3 BTG plc. Tumor Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BTG plc. Tumor Embolization Device Product Portfolio
6.7.5 BTG plc. Recent Developments/Updates
6.8 Angiodynamics
6.8.1 Angiodynamics Corporation Information
6.8.2 Angiodynamics Description and Business Overview
6.8.3 Angiodynamics Tumor Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Angiodynamics Tumor Embolization Device Product Portfolio
6.8.5 Angiodynamics Recent Developments/Updates
6.9 Siemens Healthineers
6.9.1 Siemens Healthineers Corporation Information
6.9.2 Siemens Healthineers Description and Business Overview
6.9.3 Siemens Healthineers Tumor Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Siemens Healthineers Tumor Embolization Device Product Portfolio
6.9.5 Siemens Healthineers Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tumor Embolization Device Industry Chain Analysis
7.2 Tumor Embolization Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tumor Embolization Device Production Mode & Process
7.4 Tumor Embolization Device Sales and Marketing
7.4.1 Tumor Embolization Device Sales Channels
7.4.2 Tumor Embolization Device Distributors
7.5 Tumor Embolization Device Customers
8 Tumor Embolization Device Market Dynamics
8.1 Tumor Embolization Device Industry Trends
8.2 Tumor Embolization Device Market Drivers
8.3 Tumor Embolization Device Market Challenges
8.4 Tumor Embolization Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Boston Scientific Corporation
Medtronic Inc
Terumo Corporation
Sirtex Medical Ltd.
Merit Medical
Cook Meidical LLC
BTG Plc
AngioDynamics
Siemens Healthineers
List of Tables
    Table 1. Global Tumor Embolization Device Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Tumor Embolization Device Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Tumor Embolization Device Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Tumor Embolization Device Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Tumor Embolization Device Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Tumor Embolization Device Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Tumor Embolization Device Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Tumor Embolization Device Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Tumor Embolization Device, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Tumor Embolization Device, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Tumor Embolization Device, Product Type & Application
    Table 12. Global Key Manufacturers of Tumor Embolization Device, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Tumor Embolization Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Embolization Device as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Tumor Embolization Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Tumor Embolization Device Sales by Region (2019-2024) & (K Units)
    Table 18. Global Tumor Embolization Device Sales Market Share by Region (2019-2024)
    Table 19. Global Tumor Embolization Device Sales by Region (2025-2030) & (K Units)
    Table 20. Global Tumor Embolization Device Sales Market Share by Region (2025-2030)
    Table 21. Global Tumor Embolization Device Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Tumor Embolization Device Revenue Market Share by Region (2019-2024)
    Table 23. Global Tumor Embolization Device Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Tumor Embolization Device Revenue Market Share by Region (2025-2030)
    Table 25. North America Tumor Embolization Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Tumor Embolization Device Sales by Country (2019-2024) & (K Units)
    Table 27. North America Tumor Embolization Device Sales by Country (2025-2030) & (K Units)
    Table 28. North America Tumor Embolization Device Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Tumor Embolization Device Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Tumor Embolization Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Tumor Embolization Device Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Tumor Embolization Device Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Tumor Embolization Device Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Tumor Embolization Device Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Tumor Embolization Device Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Tumor Embolization Device Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Tumor Embolization Device Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Tumor Embolization Device Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Tumor Embolization Device Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Tumor Embolization Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Tumor Embolization Device Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Tumor Embolization Device Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Tumor Embolization Device Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Tumor Embolization Device Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Tumor Embolization Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Tumor Embolization Device Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Tumor Embolization Device Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Tumor Embolization Device Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Tumor Embolization Device Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Tumor Embolization Device Sales (K Units) by Type (2019-2024)
    Table 51. Global Tumor Embolization Device Sales (K Units) by Type (2025-2030)
    Table 52. Global Tumor Embolization Device Sales Market Share by Type (2019-2024)
    Table 53. Global Tumor Embolization Device Sales Market Share by Type (2025-2030)
    Table 54. Global Tumor Embolization Device Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Tumor Embolization Device Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Tumor Embolization Device Revenue Market Share by Type (2019-2024)
    Table 57. Global Tumor Embolization Device Revenue Market Share by Type (2025-2030)
    Table 58. Global Tumor Embolization Device Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Tumor Embolization Device Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Tumor Embolization Device Sales (K Units) by Application (2019-2024)
    Table 61. Global Tumor Embolization Device Sales (K Units) by Application (2025-2030)
    Table 62. Global Tumor Embolization Device Sales Market Share by Application (2019-2024)
    Table 63. Global Tumor Embolization Device Sales Market Share by Application (2025-2030)
    Table 64. Global Tumor Embolization Device Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Tumor Embolization Device Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Tumor Embolization Device Revenue Market Share by Application (2019-2024)
    Table 67. Global Tumor Embolization Device Revenue Market Share by Application (2025-2030)
    Table 68. Global Tumor Embolization Device Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Tumor Embolization Device Price (US$/Unit) by Application (2025-2030)
    Table 70. Boston Scientific Corporation Corporation Information
    Table 71. Boston Scientific Corporation Description and Business Overview
    Table 72. Boston Scientific Corporation Tumor Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Boston Scientific Corporation Tumor Embolization Device Product
    Table 74. Boston Scientific Corporation Recent Developments/Updates
    Table 75. Medtronic plc. Corporation Information
    Table 76. Medtronic plc. Description and Business Overview
    Table 77. Medtronic plc. Tumor Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Medtronic plc. Tumor Embolization Device Product
    Table 79. Medtronic plc. Recent Developments/Updates
    Table 80. Terumo Corporation Corporation Information
    Table 81. Terumo Corporation Description and Business Overview
    Table 82. Terumo Corporation Tumor Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Terumo Corporation Tumor Embolization Device Product
    Table 84. Terumo Corporation Recent Developments/Updates
    Table 85. Sirtex Medical ltd. Corporation Information
    Table 86. Sirtex Medical ltd. Description and Business Overview
    Table 87. Sirtex Medical ltd. Tumor Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Sirtex Medical ltd. Tumor Embolization Device Product
    Table 89. Sirtex Medical ltd. Recent Developments/Updates
    Table 90. Merit Medical Corporation Information
    Table 91. Merit Medical Description and Business Overview
    Table 92. Merit Medical Tumor Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Merit Medical Tumor Embolization Device Product
    Table 94. Merit Medical Recent Developments/Updates
    Table 95. Cook Meidical LLC Corporation Information
    Table 96. Cook Meidical LLC Description and Business Overview
    Table 97. Cook Meidical LLC Tumor Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Cook Meidical LLC Tumor Embolization Device Product
    Table 99. Cook Meidical LLC Recent Developments/Updates
    Table 100. BTG plc. Corporation Information
    Table 101. BTG plc. Description and Business Overview
    Table 102. BTG plc. Tumor Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. BTG plc. Tumor Embolization Device Product
    Table 104. BTG plc. Recent Developments/Updates
    Table 105. Angiodynamics Corporation Information
    Table 106. Angiodynamics Description and Business Overview
    Table 107. Angiodynamics Tumor Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Angiodynamics Tumor Embolization Device Product
    Table 109. Angiodynamics Recent Developments/Updates
    Table 110. Siemens Healthineers Corporation Information
    Table 111. Siemens Healthineers Description and Business Overview
    Table 112. Siemens Healthineers Tumor Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Siemens Healthineers Tumor Embolization Device Product
    Table 114. Siemens Healthineers Recent Developments/Updates
    Table 115. Key Raw Materials Lists
    Table 116. Raw Materials Key Suppliers Lists
    Table 117. Tumor Embolization Device Distributors List
    Table 118. Tumor Embolization Device Customers List
    Table 119. Tumor Embolization Device Market Trends
    Table 120. Tumor Embolization Device Market Drivers
    Table 121. Tumor Embolization Device Market Challenges
    Table 122. Tumor Embolization Device Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Tumor Embolization Device
    Figure 2. Global Tumor Embolization Device Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Tumor Embolization Device Market Share by Type in 2023 & 2030
    Figure 4. Cancer Tumors Embolization Device Product Picture
    Figure 5. Noncancerous Tumors Embolization Device Product Picture
    Figure 6. Global Tumor Embolization Device Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Tumor Embolization Device Market Share by Application in 2023 & 2030
    Figure 8. Hospitals
    Figure 9. Clinics
    Figure 10. Others
    Figure 11. Global Tumor Embolization Device Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Tumor Embolization Device Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Tumor Embolization Device Sales (2019-2030) & (K Units)
    Figure 14. Global Tumor Embolization Device Average Price (US$/Unit) & (2019-2030)
    Figure 15. Tumor Embolization Device Report Years Considered
    Figure 16. Tumor Embolization Device Sales Share by Manufacturers in 2023
    Figure 17. Global Tumor Embolization Device Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Tumor Embolization Device Players: Market Share by Revenue in 2023
    Figure 19. Tumor Embolization Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Tumor Embolization Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Tumor Embolization Device Sales Market Share by Country (2019-2030)
    Figure 22. North America Tumor Embolization Device Revenue Market Share by Country (2019-2030)
    Figure 23. United States Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Tumor Embolization Device Sales Market Share by Country (2019-2030)
    Figure 26. Europe Tumor Embolization Device Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Tumor Embolization Device Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Tumor Embolization Device Revenue Market Share by Region (2019-2030)
    Figure 34. China Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. China Taiwan Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Latin America Tumor Embolization Device Sales Market Share by Country (2019-2030)
    Figure 44. Latin America Tumor Embolization Device Revenue Market Share by Country (2019-2030)
    Figure 45. Mexico Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Brazil Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Argentina Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Tumor Embolization Device Sales Market Share by Country (2019-2030)
    Figure 49. Middle East & Africa Tumor Embolization Device Revenue Market Share by Country (2019-2030)
    Figure 50. Turkey Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. UAE Tumor Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Global Sales Market Share of Tumor Embolization Device by Type (2019-2030)
    Figure 54. Global Revenue Market Share of Tumor Embolization Device by Type (2019-2030)
    Figure 55. Global Tumor Embolization Device Price (US$/Unit) by Type (2019-2030)
    Figure 56. Global Sales Market Share of Tumor Embolization Device by Application (2019-2030)
    Figure 57. Global Revenue Market Share of Tumor Embolization Device by Application (2019-2030)
    Figure 58. Global Tumor Embolization Device Price (US$/Unit) by Application (2019-2030)
    Figure 59. Tumor Embolization Device Value Chain
    Figure 60. Tumor Embolization Device Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Lymphoma Therapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-10S14319
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Gene Therapy on Cancer Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-3X14503
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Internal Radiotherapy Devices Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-10C14318
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Remote Afterloading System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34B7845
Sun May 19 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions